MIT Biotechnology Group

MBG Lunch Seminar with Liz O’Day, CEO and Founder of Olaris Therapeutics

MBG Lunch Seminar with Liz O’Day, CEO and Founder of Olaris Therapeutics 
Tuesday, August 25th, 12:00 pm -1:00 pm
Location will be announced to event participants

Join MBG for lunch seminar with Liz O’Day, CEO and founder of Olaris Therapeutics. The seminar is a closed event (RSVP only) that will be limited to 30 people; the first 30 to signup will receive a confirmation and further event details. Lunch from clover will be provided.

Please RSVP at


Dr. Elizabeth O’Day is the CEO and Founder of Olaris Therapeutics a pharmaceutical company that develops precision medicines for diseases with little to no treatment options and dismal survival rates. Olaris technology will fundamentally change how these diseases are treated and diagnosed. Dr. O’Day is also the founder of Lizzard Fashion, an apparel company that uses fashion to promote science. Like feedback loops studied by scientists, science inspires fashion and fashion supports science. Partial Lizzard proceeds support cancer research. Additionally, Dr. O’Day initiated Proyecto Chispa (Project Spark), which recycles electronics and uses the resale of parts to build computer centers in orphanages throughout Latin America. She is also the founder of “Women in Science & Technology” (WST) at Boston College. WST is in its 9th year and has provided over 500 high-school-aged females and college students the opportunity to learn about careers in science. Dr. O’Day received her PhD from Harvard University. where she was a National Science Foundation fellow. She was one of eleven America scientists awarded a Winston Churchill fellowship and received a Master’s of Philosophy in Chemistry from the University of Cambridge. She has a Bachelors of Science degree from Boston College in Biochemistry. She was also selected as a World Economic Forum Global Shaper, which recognizes young people who are exceptional in their potential, their achievements and their drive to make a contribution to their communities.